Literature DB >> 1531069

Comparison of same-day protocols using technetium-99m-sestamibi myocardial imaging.

J Heo1, J Kegel, A S Iskandrian, V Cave, B B Iskandrian.   

Abstract

Two same-day protocols (rest/exercise [Protocol 1] and exercise/rest [Protocol 2]) with sestamibi (hexakis 2-methoxy-2-isobutyl-isonitrile) were performed within 2 to 14 days of each other after randomization. The initial study in each protocol was done using a dose of 185-296 MBq of 99mTc-sestamibi. The second study in each protocol used a dose of 555-925 MBq. SPECT imaging was started 30 to 60 min after injection using a 180 degrees anterior arc. Segmental analysis was interpreted as normal, scar or ischemia (20 segments/patient). Among the protocols, there was concordance in 93% of the segments (593/640 segments). In the 11 patients with coronary artery disease and no prior myocardial infarction who had ischemic abnormality, count densities from abnormal and normal zones were compared between the two protocols. Protocol 1 showed greater count differences between abnormal and normal zones on exercise images with better normalization of abnormality on rest images than Protocol 2 (p less than 0.05). Technetium-99m-sestamibi provides high quality images using either of the two same-day protocols. However, the rest/exercise protocol provides better image contrast and ability to detect reversibility of perfusion defects, and is the preferred same-day protocol.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1531069

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  20 in total

1.  Noninvasive Cardiac Imaging in Chest Pain Syndromes.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1998-11       Impact factor: 2.300

Review 2.  An overview of contemporary nuclear cardiology.

Authors:  Howard C Lewin; Maria G Sciammarella; Thomas A Watters; Herbert G Alexander
Journal:  Curr Cardiol Rep       Date:  2004-01       Impact factor: 2.931

3.  EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology.

Authors:  B Hesse; K Tägil; A Cuocolo; C Anagnostopoulos; M Bardiés; J Bax; F Bengel; E Busemann Sokole; G Davies; M Dondi; L Edenbrandt; P Franken; A Kjaer; J Knuuti; M Lassmann; M Ljungberg; C Marcassa; P Y Marie; F McKiddie; M O'Connor; E Prvulovich; R Underwood; B van Eck-Smit
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-07       Impact factor: 9.236

4.  Role of the technologist in nuclear cardiology.

Authors:  A Mann; M P White
Journal:  J Nucl Cardiol       Date:  1998 Jul-Aug       Impact factor: 5.952

5.  Furifosmin: the road to the final four.

Authors:  A S Iskandrian
Journal:  J Nucl Cardiol       Date:  1996 Jul-Aug       Impact factor: 5.952

Review 6.  The future of SPECT MPI: time and dose reduction.

Authors:  Milena J Henzlova; W Lane Duvall
Journal:  J Nucl Cardiol       Date:  2011-08       Impact factor: 5.952

7.  The birth of a new radiopharmaceutical. Clinical investigative perspective.

Authors:  F J Wackers
Journal:  J Nucl Cardiol       Date:  1995 Jan-Feb       Impact factor: 5.952

Review 8.  Choosing a thallium-201 or technetium 99m sestamibi imaging protocol.

Authors:  J E Udelson
Journal:  J Nucl Cardiol       Date:  1994 Sep-Oct       Impact factor: 5.952

Review 9.  The maze of myocardial perfusion imaging protocols in 1994.

Authors:  F J Wackers
Journal:  J Nucl Cardiol       Date:  1994 Mar-Apr       Impact factor: 5.952

10.  Nuclear cardiology as it should look in the twenty-first century.

Authors:  W Lane Duvall; Milena J Henzlova
Journal:  J Nucl Cardiol       Date:  2015-05-14       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.